Decline in brain age observed among hospitalized COVID-19 patients: Research

Symptoms associated with the brain are often reported by patients infected with the coronavirus and persist even after the disease has been defeated.

Now, a new study claims that COVID-19 increases the levels of biomarkers in hospitalized patients that indicate a decline in brain age.

This was revealed in a medical study conducted in the United States.

Experts from the New York University Grossman School of Medicine identified an increase in the levels of such biomarkers, including neuronal, gallbladder and others.

Levels of the neuronal, gallbladder and other biomarkers have been shown to significantly increase the number of patients undergoing treatment in the hospital due to COVID-19 and can also predict the severity of the disease.

The study included people who had no history of dementia, a disease that causes dementia, but nevertheless had a higher level of degradation with age than Alzheimer’s patients.

The study included 251 patients undergoing treatment for COVID-19 with no history of dementia or cerebral palsy.

The average age of these patients was 71 years and 31% needed ventilator support, 25% died and 53% were able to overcome the disease.

The 161 people included those who were protected by COVID-19 and used as a control group.

Of these, 54 were completely mentally healthy, 54 had partial brain damage and 53 had Alzheimer’s disease.

The study found that 48% of patients with COVID-19 suffered from mental and neurological symptoms, and 46% also suffered from brain injury.

The researchers found that patients with COVID-19 may experience dementia problems in the elderly and with severe COD.

It said that patients with severe brain disease who had low oxygen levels and needed a ventilator had elevated levels of biomarkers of cerebral palsy.

Similarly, the levels of these biomarkers were significantly higher in patients who died in the hospital than in those who died of the disease.

The findings suggest that code may increase the risk of dementia, but more research is needed.

The results of this study were not published in any medical journal but on the preprint server medRxiv.

Earlier, in June 2021, a study by the University of Cleveland in the United States stated that patients may suffer from dementias such as Alzheimer’s as a result of COVID-19.

Research has suggested that there is a link between COVID-19 and the brain changes that occur during Alzheimer’s.

The researchers said that some research reports indicated that the coronavirus directly affects brain cells, while others found no such evidence.

“Identifying how COVID-19 is a disease that causes mental problems is essential to discovering an effective treatment,” they said.

Also Read

Snake venom, possible cure for COVID-19?

New research suggests that the venom of a particular type of snake...